The Function of Host-derived Extracellular Vesicles in Trafficking of Bacterial Antigens to Stimulate the Antibacterial Immune Response
宿主来源的细胞外囊泡在细菌抗原运输中刺激抗菌免疫反应的功能
基本信息
- 批准号:10443148
- 负责人:
- 金额:$ 54.33万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-04-12 至 2027-03-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAdvanced DevelopmentAffectAnimalsAnti-Bacterial AgentsAntibodiesAntigen PresentationAntigen-Presenting CellsAntigensAutophagocytosisBacteriaBacterial AntigensBacterial InfectionsBone MarrowCD4 Positive T LymphocytesCell CommunicationCell physiologyCellsCellular ImmunityCessation of lifeDataDendritic CellsDevelopmentFecesFood ContaminationFutureGastroenteritisGenus MycobacteriumGoalsHost DefenseHumanHumoral ImmunitiesITGAM geneImmuneImmune responseImmune signalingImmune systemImmunityInfectionInfiltrationIntranasal AdministrationKnowledgeLeadLifeMediatingMissionMucous MembraneMusMycobacterium tuberculosisNational Institute of Allergy and Infectious DiseaseNatural ImmunityOutcomePathogenicityPathway interactionsPharmaceutical PreparationsPhenotypePreventive measureProcessProductionProteinsPublic HealthPublishingRNAResearchRoleSalmonellaSalmonella entericaSalmonella infectionsSalmonella typhimuriumSepticemiaSubunit VaccinesT-Cell ActivationT-LymphocyteTh1 CellsTherapeuticVaccine DesignVaccinesVesicleWater consumptionacid fast bacteriaadaptive immune responseadaptive immunitybasecytokinedesignexosomeextracellular vesiclesinnovationintercellular communicationlymph nodesmacrophagemigrationmouse modelnanoscalenovelpathogenrecruitresponsetrafficking
项目摘要
There is no licensed vaccine for humans against potentially life-threatening paratyphoid and nontyphoidal
septicemia caused by the Salmonella enterica. This intracellular pathogen evades sophisticated host immune
defenses. The host immune system is controlled by regulatory mechanisms, such as intercellular communication
between infected and uninfected cells, which can also be accomplished via small extracellular vesicles (EVs),
exosomes. Exosomes are vesicles that originate in the endosomal pathway and transport cargo to other cells.
We found that exosomes carry bacterial antigens (Ags) from S. Typhimurium-infected macrophages (
MΦ
s) and
stimulate naïve antigen-presenting cells involved in T cell recruitment, and an intranasal administration of these
exosomes leads to the production of anti-S. Typhimurium antibodies (Abs) and stimulation of Th 1 response
critical for engulfing and killing intracellular bacteria. These adaptive responses are Ags-dependent, but the Ags
responsible for this humoral response or the mechanisms responsible for Ag trafficking to EVs are unknown. We
will address the contribution of exosomes to adaptive immune responses against intracellular pathogens as there
is a critical need to determine new mechanisms of protective immune responses, such as exosome-modulated
immunity. Our long-term goal is to advance the development of mechanism-based preventative measures for
bacterial infections. Our overall objective is to elucidate the mechanisms whereby bacterial Ags are trafficked to
exosomes and identify the capability of exosomes to generate protective cellular and humoral immunity against
intracellular Salmonella. Our central hypothesis is that Salmonella Ags are trafficked to endosomal
compartments of infected MΦs and released via exosomes to stimulate innate responses and Ag-specific
Th1
cell responses
. The rationale is that determining the mechanisms via which Salmonella Ags are trafficked to
exosomes and generate adaptive immunity against Salmonella, we will assign a novel role of EVs in host
defense, important for the design of preventative approaches. In Aim 1, we will identify mechanisms whereby
Salmonella Ags are trafficked into EVs. In Aim 2, we will determine the mechanisms by which EVs produced by
Salmonella-infected
determine how EVs
MΦ
s regulate the activation and function of DCs in mucosal tissues. In Aim 3, we will
derived from Salmonella-infected
MΦ
s drive adaptive immunity. The expected outcomes
are that we will have established a mechanism responsible for the trafficking of Ags into EVs, and characterize
novel roles of EVs in innate immunity and Th1 adaptive immunity. This study will have a positive impact as it will
provide a conceptual framework for the future development of targets for vaccine design and significantly
advance knowledge of how Salmonella disrupts host immunity, which is vital for the development of preventative
and therapeutic approaches against this pathogen. The innovation lies in addressing the function of EVs
produced by host cells in rendering protection against salmonellosis. This study is significant since we will
advance knowledge on the function of host exosomes in altering the immune response to Salmonella infection.
目前还没有获得许可的人类预防潜在威胁生命的副伤寒和非伤寒的疫苗
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mariola Jadwiga Ferraro其他文献
Mariola Jadwiga Ferraro的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mariola Jadwiga Ferraro', 18)}}的其他基金
The Function of Host-derived Extracellular Vesicles in Trafficking of Bacterial Antigens to Stimulate the Antibacterial Immune Response
宿主来源的细胞外囊泡在细菌抗原运输中刺激抗菌免疫反应的功能
- 批准号:
10609082 - 财政年份:2022
- 资助金额:
$ 54.33万 - 项目类别:
相似海外基金
ADVANCED DEVELOPMENT OF LQ A LIPOSOME-BASED SAPONIN-CONTAINING ADJUVANT FOR USE IN PANSARBECOVIRUS VACCINES
用于 Pansarbecovirus 疫苗的 LQ A 脂质体含皂苷佐剂的先进开发
- 批准号:
10935820 - 财政年份:2023
- 资助金额:
$ 54.33万 - 项目类别:
ADVANCED DEVELOPMENT OF BBT-059 AS A RADIATION MEDICAL COUNTERMEASURE FOR DOSING UP TO 48H POST EXPOSURE"
BBT-059 的先进开发,作为辐射医学对策,可在暴露后 48 小时内进行给药”
- 批准号:
10932514 - 财政年份:2023
- 资助金额:
$ 54.33万 - 项目类别:
Advanced Development of a Combined Shigella-ETEC Vaccine
志贺氏菌-ETEC 联合疫苗的先进开发
- 批准号:
10704845 - 财政年份:2023
- 资助金额:
$ 54.33万 - 项目类别:
Advanced development of composite gene delivery and CAR engineering systems
复合基因递送和CAR工程系统的先进开发
- 批准号:
10709085 - 财政年份:2023
- 资助金额:
$ 54.33万 - 项目类别:
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
- 批准号:
10409385 - 财政年份:2022
- 资助金额:
$ 54.33万 - 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
针对大流行和突发冠状病毒的疫苗的高级开发
- 批准号:
10710595 - 财政年份:2022
- 资助金额:
$ 54.33万 - 项目类别:
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
- 批准号:
10630975 - 财政年份:2022
- 资助金额:
$ 54.33万 - 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE CANDIDATE FOR STAPHYLOCOCCUS AUREUS INFECTION
金黄色葡萄球菌感染候选疫苗的高级开发
- 批准号:
10710588 - 财政年份:2022
- 资助金额:
$ 54.33万 - 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
针对大流行和突发冠状病毒的疫苗的高级开发
- 批准号:
10788051 - 财政年份:2022
- 资助金额:
$ 54.33万 - 项目类别:














{{item.name}}会员




